Calyxt (CLXT) Receives EU Patent on Use of CRISPR/Cas9 for Genome Editing in Plants – StreetInsider.com

Calyxt (CLXT) Receives EU Patent on Use of CRISPR/Cas9 for Genome Editing in Plants  StreetInsider.com

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here. Calyxt, Inc. (NASDAQ: CLXT), …